Millennium Management’s ARK Genomic Revolution ETF ARKG Stock Holding History

Millennium Management’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-22,039	Closed	-$519K	–	5824
2024 Q4	$519K	Sell	22,039 -91,323	-81%	-$2.25M	﹤0.01%	4722
2024 Q3	$2.9M	Sell	113,362 -16,142	-12%	-$411K	﹤0.01%	3351
2024 Q2	$3.04M	Buy	129,504 +74,590	+136%	+$1.88M	﹤0.01%	3168
2024 Q1	$1.58M	Sell	54,914 -524	-0.9%	-$15.8K	﹤0.01%	3931
2023 Q4	$1.82M	Buy	55,438 +42,800	+339%	+$1.16M	﹤0.01%	3690
2023 Q3	$352K	Buy	+12,638	New	+$413K	﹤0.01%	4851
2023 Q1	–	Sell	-65,630	Closed	-$2.03M	–	6333
2022 Q4	$1.85M	Sell	65,630 -7,647	-10%	-$243K	﹤0.01%	3637
2022 Q3	$2.41M	Buy	+73,277	New	+$2.69M	﹤0.01%	3581
2022 Q2	–	Sell	-34,481	Closed	-$1.21M	–	6940
2022 Q1	$1.58M	Buy	34,481 +23,994	+229%	+$1.14M	﹤0.01%	4086
2021 Q4	$642K	Sell	10,487 -53,036	-83%	-$3.67M	﹤0.01%	4825
2021 Q3	$4.75M	Buy	63,523 +18,268	+40%	+$1.53M	﹤0.01%	2921
2021 Q2	$4.19M	Sell	45,255 -60,467	-57%	-$5.14M	﹤0.01%	2988
2021 Q1	$9.38M	Buy	105,722 +100,408	+1,889%	+$9.96M	0.01%	1851
2020 Q4	$496K	Buy	+5,314	New	+$423K	﹤0.01%	4199
2020 Q3	–	Sell	-7,651	Closed	-$399K	–	4417
2020 Q2	$399K	Buy	+7,651	New	+$328K	﹤0.01%	3538

Other funds holding ARKG

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Millennium Management's ARKG Position: Q1 2025 in Review

Millennium Management sold out of ARK Genomic Revolution ETF (ARKG) in Q1 2025, closing a stake of 22,039 shares — an estimated $519K sold.

Millennium Management first reported a position in ARKG in Q2 2020 and held it in 15 quarters. The position peaked at $9.38M in Q1 2021. 214 funds tracked by Wall St. Rank hold ARKG as of Q1 2025.

Millennium Management reported no remaining ARK Genomic Revolution ETF position as of Q1 2025 after selling out during the quarter.
Millennium Management sold 22,039 ARK Genomic Revolution ETF shares in Q1 2025, an estimated $519K.
Millennium Management first reported a position in ARK Genomic Revolution ETF in Q2 2020 and held it in 15 quarters.
Millennium Management's ARK Genomic Revolution ETF position peaked at $9.38M in Q1 2021.
214 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q1 2025.

Based on Millennium Management's 13F filing for Q1 2025, filed 15 May 2025.